Dr. Jeffrey Rothstein to give visiting professor lecture Dec. 12
Dr. Jeffrey D. Rothstein will be in Ann Arbor on Dec. 12 to present a Visiting Professor/Grand Rounds lecture, "Glia as Unexpected Contributors to ALS and Neurodegeneration: A New Toolbox for Therapy."
The lecture is sponsored by the Taubman Institute and the U-M Medical School Dept. of Neurology, and will take place from 10:30 to 11:30 a.m. on Dec. 12 in the Marvin and Betty Danto Auditorium at the U-M cardiovascular center.
Dr. Rothstein is a professor of neurology and neuroscience at Johns Hopkins University, and director of the school's Robert Packard Center for ALS Research. He also serves as the John W. Griffin Director of the Brain Science Institute.
CME credit is available.
Taubman-sponsored research offers breast tumor insights
Taubman Emerging Scholar Dr. Scott Tomlins has authored a new study about phyllodes tumors.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
Familial ALS affects generations
Detroit News column featuring Dr. Eva Feldman depicts the toll of the disease on one Metro Detroit family
news & events
In the News
PBS series features institute director on Jan. 18
"The Embrace of Aging," a documentary series airing Sundays at 2:30 p.m. on Detroit Public Televsion, features Taubman Institute Director Eva Feldman, M.D., Ph.D. and her landmark ALS stem cell trial in the Jan. 18 episode.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.